Stock listing
NSE:IKS Inventurus Knowledge Solutions Limited Share Price
Home listing (NSE) of Inventurus Knowledge Solutions Limited
Follow Inventurus Knowledge Solutions Limited into a list and get an email when it puts out news.
Share price · NSE:IKS
₹1,640.80 INR +30.70 (+1.9%)
Close on Nov 20, 2026
- Day range
- ₹1,590.90 – ₹1,648.00 INRNov 20, 2026
- Volume
- 95,053 sharesNov 20, 2026
- Market cap
- ₹275.3B INRAt the close on Nov 20, 2026 · price × 167.8M shares outstanding
- 52-week range
- ₹1,262.00 – ₹1,970.00 INRLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₹273.8M INRMedian day 118,974 shares · 2 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NSE:IKS · Home | ₹1,640.80 INR | +30.70 (+1.9%) | 95,053 | ₹1,605.80 | ₹1,648.00 | ₹1,590.90 | ₹1,610.10 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NSE:IKS · INR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₹1,640.80 | +30.70 | +1.9% | ₹1,605.80 | ₹1,648.00 | ₹1,590.90 | 95,053 | |
| ₹1,610.10 | -20.00 | -1.2% | ₹1,620.00 | ₹1,627.00 | ₹1,600.00 | 79,319 | |
| ₹1,630.10 | +11.20 | +0.7% | ₹1,619.50 | ₹1,647.40 | ₹1,607.60 | 72,797 | |
| ₹1,618.90 | -15.20 | -0.9% | ₹1,634.90 | ₹1,639.90 | ₹1,608.40 | 66,788 | |
| ₹1,634.10 | -34.00 | -2.0% | ₹1,652.50 | ₹1,668.10 | ₹1,628.40 | 165,265 | |
| ₹1,668.10 | +7.90 | +0.5% | ₹1,663.40 | ₹1,674.20 | ₹1,643.00 | 154,402 | |
| ₹1,660.20 | +8.90 | +0.5% | ₹1,661.30 | ₹1,679.30 | ₹1,638.30 | 133,202 | |
| ₹1,651.30 | -5.80 | -0.4% | ₹1,710.00 | ₹1,724.90 | ₹1,618.80 | 326,561 | |
| ₹1,657.10 | -100.10 | -5.7% | ₹1,726.90 | ₹1,726.90 | ₹1,627.80 | 184,985 | |
| ₹1,757.20 | +6.80 | +0.4% | ₹1,770.00 | ₹1,799.10 | ₹1,751.00 | 118,061 | |
| ₹1,750.40 | +20.50 | +1.2% | ₹1,730.00 | ₹1,760.50 | ₹1,712.40 | 59,459 | |
| ₹1,729.90 | +3.20 | +0.2% | ₹1,726.70 | ₹1,740.20 | ₹1,715.60 | 47,288 | |
| ₹1,726.70 | +22.90 | +1.3% | ₹1,694.00 | ₹1,730.80 | ₹1,684.10 | 60,184 | |
| ₹1,703.80 | -7.10 | -0.4% | ₹1,700.00 | ₹1,725.30 | ₹1,678.90 | 86,561 | |
| ₹1,710.90 | +18.10 | +1.1% | ₹1,685.50 | ₹1,725.00 | ₹1,679.60 | 55,910 | |
| ₹1,692.80 | -10.20 | -0.6% | ₹1,703.00 | ₹1,711.20 | ₹1,673.10 | 68,357 | |
| ₹1,703.00 | +43.10 | +2.6% | ₹1,651.20 | ₹1,710.00 | ₹1,650.00 | 82,401 | |
| ₹1,659.90 | +41.90 | +2.6% | ₹1,605.60 | ₹1,670.30 | ₹1,585.60 | 95,709 | |
| ₹1,618.00 | -30.00 | -1.8% | ₹1,635.20 | ₹1,656.20 | ₹1,582.50 | 234,204 | |
| ₹1,648.00 | +16.30 | +1.0% | ₹1,620.00 | ₹1,658.00 | ₹1,598.10 | 141,580 | |
| ₹1,631.70 | -54.10 | -3.2% | ₹1,675.00 | ₹1,698.90 | ₹1,613.00 | 304,182 | |
| ₹1,685.80 | -45.60 | -2.6% | ₹1,745.80 | ₹1,745.80 | ₹1,678.00 | 68,271 | |
| ₹1,731.40 | +13.40 | +0.8% | ₹1,718.40 | ₹1,740.00 | ₹1,705.20 | 54,839 | |
| ₹1,718.00 | -11.60 | -0.7% | ₹1,710.00 | ₹1,770.00 | ₹1,710.00 | 86,098 | |
| ₹1,729.60 | -14.00 | -0.8% | ₹1,728.10 | ₹1,759.90 | ₹1,721.70 | 59,055 | |
| ₹1,743.60 | +19.50 | +1.1% | ₹1,730.00 | ₹1,749.80 | ₹1,700.00 | 93,001 | |
| ₹1,724.10 | +7.50 | +0.4% | ₹1,716.60 | ₹1,751.20 | ₹1,689.00 | 97,619 | |
| ₹1,716.60 | -34.50 | -2.0% | ₹1,745.00 | ₹1,773.90 | ₹1,708.10 | 132,974 | |
| ₹1,751.10 | +13.70 | +0.8% | ₹1,745.00 | ₹1,791.60 | ₹1,742.20 | 236,677 | |
| ₹1,737.40 | -23.60 | -1.3% | ₹1,752.40 | ₹1,759.00 | ₹1,693.30 | 330,080 | |
| ₹1,761.00 | -5.80 | -0.3% | ₹1,758.10 | ₹1,777.10 | ₹1,745.50 | 66,106 | |
| ₹1,766.80 | -9.60 | -0.5% | ₹1,791.00 | ₹1,798.30 | ₹1,742.50 | 119,886 | |
| ₹1,776.40 | 0.00 | 0.0% | ₹1,776.40 | ₹1,776.40 | ₹1,776.40 | 0 | |
| ₹1,776.40 | +28.90 | +1.7% | ₹1,747.00 | ₹1,783.80 | ₹1,726.10 | 149,999 | |
| ₹1,747.50 | -31.90 | -1.8% | ₹1,782.90 | ₹1,800.50 | ₹1,740.30 | 152,839 | |
| ₹1,779.40 | +11.00 | +0.6% | ₹1,768.00 | ₹1,822.30 | ₹1,750.70 | 203,931 | |
| ₹1,768.40 | -47.40 | -2.6% | ₹1,815.80 | ₹1,815.80 | ₹1,755.50 | 137,087 | |
| ₹1,815.80 | -52.50 | -2.8% | ₹1,867.10 | ₹1,874.00 | ₹1,804.60 | 224,086 | |
| ₹1,868.30 | -69.50 | -3.6% | ₹1,920.00 | ₹1,940.00 | ₹1,849.00 | 366,105 | |
| ₹1,937.80 | +68.60 | +3.7% | ₹1,881.20 | ₹1,970.00 | ₹1,871.00 | 1,011,998 | |
| ₹1,869.20 | +86.40 | +4.8% | ₹1,771.70 | ₹1,886.00 | ₹1,771.30 | 486,580 | |
| ₹1,782.80 | +2.90 | +0.2% | ₹1,780.00 | ₹1,797.00 | ₹1,769.70 | 158,305 | |
| ₹1,779.90 | +51.00 | +2.9% | ₹1,721.00 | ₹1,795.50 | ₹1,721.00 | 451,923 | |
| ₹1,728.90 | -23.10 | -1.3% | ₹1,743.50 | ₹1,771.10 | ₹1,712.70 | 119,965 | |
| ₹1,752.00 | -31.00 | -1.7% | ₹1,767.10 | ₹1,786.20 | ₹1,744.90 | 129,237 | |
| ₹1,783.00 | +42.40 | +2.4% | ₹1,762.80 | ₹1,800.00 | ₹1,747.00 | 172,263 | |
| ₹1,740.60 | 0.00 | 0.0% | ₹1,740.60 | ₹1,740.60 | ₹1,740.60 | 0 | |
| ₹1,740.60 | -43.10 | -2.4% | ₹1,783.00 | ₹1,783.00 | ₹1,732.40 | 83,326 | |
| ₹1,783.70 | -8.40 | -0.5% | ₹1,782.00 | ₹1,802.20 | ₹1,770.70 | 76,060 | |
| ₹1,792.10 | +12.10 | +0.7% | ₹1,789.00 | ₹1,849.00 | ₹1,762.70 | 206,160 | |
| ₹1,780.00 | -8.00 | -0.4% | ₹1,800.00 | ₹1,813.20 | ₹1,769.80 | 67,890 | |
| ₹1,788.00 | +28.10 | +1.6% | ₹1,769.80 | ₹1,799.00 | ₹1,752.40 | 127,280 | |
| ₹1,759.90 | +27.50 | +1.6% | ₹1,728.50 | ₹1,799.80 | ₹1,728.50 | 220,451 | |
| ₹1,732.40 | -11.70 | -0.7% | ₹1,740.90 | ₹1,763.80 | ₹1,717.90 | 61,480 | |
| ₹1,744.10 | +3.30 | +0.2% | ₹1,740.80 | ₹1,748.00 | ₹1,712.10 | 78,597 | |
| ₹1,740.80 | +6.50 | +0.4% | ₹1,770.00 | ₹1,788.00 | ₹1,725.00 | 142,656 | |
| ₹1,734.30 | -27.70 | -1.6% | ₹1,755.10 | ₹1,779.30 | ₹1,715.50 | 285,121 | |
| ₹1,762.00 | +11.40 | +0.7% | ₹1,743.00 | ₹1,778.00 | ₹1,740.50 | 110,044 | |
| ₹1,750.60 | +9.20 | +0.5% | ₹1,741.40 | ₹1,771.00 | ₹1,724.00 | 180,738 | |
| ₹1,741.40 | -49.50 | -2.8% | ₹1,787.00 | ₹1,790.90 | ₹1,726.20 | 231,100 | |
| ₹1,790.90 | +1.50 | +0.1% | ₹1,775.60 | ₹1,800.00 | ₹1,766.20 | 60,597 | |
| ₹1,789.40 | +3.20 | +0.2% | ₹1,787.90 | ₹1,820.40 | ₹1,776.10 | 100,047 | |
| ₹1,786.20 | -5.40 | -0.3% | ₹1,788.20 | ₹1,806.80 | ₹1,769.60 | 90,179 | |
| ₹1,791.60 | -20.70 | -1.1% | ₹1,826.90 | ₹1,836.00 | ₹1,771.70 | 87,771 |
- Ticker
- NSE:IKS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- NSE
- Currency
- INR
What changed lately
Latest news release · Nov 5, 2026
Inventurus Knowledge Solutions Limited has informed the Exchange regarding a press release dated November 05, 2026, titled "IKS Health s Q2 FY27 Earnings Reflect Strong Momentum with 104 % Revenue and 62.5% EBITDA YoY Growth."
Latest earnings call · Nov 6, 2026
Inventurus Knowledge Solutions (NSE:IKS) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Nov 5, 2026
Q2 FY27 Earnings Presentation
Earnings · 19 slides
Latest news
Inventurus Knowledge Solutions Limited has informed the Exchange regarding a press release dated November 05, 2026, titled "IKS Health s Q2 FY27 Earnings Reflect Strong Momentum with 104 % Revenue and 62.5% EBITDA YoY Growth."
Nov 5, 2026
Closed ₹1,657.10 (-5.7%) on Nov 6, 2026
Inventurus Knowledge Solutions Limited Press Release Aug 05 2026
Aug 5, 2026
Closed ₹1,763.10 (-6.1%) on Aug 6, 2026
Inventurus Knowledge Solutions Limited Press Release Jul 09 2026
Jul 9, 2026
Closed ₹1,928.10 (+3.5%) on Jul 10, 2026
Inventurus Knowledge Solutions Limited Press Release Jun 30 2026
Jun 30, 2026
Closed ₹1,800.20 (+7.2%) on Jul 1, 2026
Press Release May 13 2026
May 13, 2026
Closed ₹1,672.90 (-0.1%) on May 14, 2026
Press Release May 05 2026
May 5, 2026
Closed ₹1,665.50 (-1.3%) on May 6, 2026
Press Release Apr 23 2026
Apr 23, 2026
Closed ₹1,438.00 (+0.2%) on Apr 24, 2026
IKS Health Announces Agreement to Acquire TruBridge to Strengthen Access to Rural and Community-Based Healthcare
Apr 23, 2026
Closed ₹1,438.00 (+0.2%) on Apr 24, 2026
Certilytics and IKS Health Bolster Strategic Partnership with New Agentic AI and Expert-in-the-Loop Oversight to Improve Healthcare Workflows and Impact Across the Patient Journey
Apr 21, 2026
Closed ₹1,426.90 (-0.8%) on Apr 22, 2026
Press Release Apr 15 2026
Apr 15, 2026
Closed ₹1,522.40 (+0.4%) on Apr 16, 2026
Inventurus Knowledge Solutions Limited on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 17 in the last 12 months · 38 in all · newest Nov 5, 2026 · oldest 2025
- Calls
- 2 calls with a replay · 2 with a transcript · latest Nov 6, 2026
- Decks
- 19 decks · latest Nov 5, 2026
Where Inventurus Knowledge Solutions Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NSE:IKS · Home listing · This page | NSE | India | INR |
| BSE:IKS | BSE | India | INR |
Valuation
P/E 36.0× against a median of 29.3×: 6th lowest of 8 Health care services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₹275.3B INR
- P/E
- 36.0×
- EV/sales
- 8.2×
- EV/EBITDA
- 23.3×
- Price/book
- 9.8×
- Gross margin
- 44.6%
- Operating margin
- 31.5%
- Net margin
- 22.8%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Inventurus Knowledge Solutions Limited · NSE:IKS | US$2.97B | US$2.97B | 36.0× | 8.2× | 23.3× | 9.8× | 22.8% | 0.0× | n/a |
| Surgery Partners, Inc. · NASDAQ:SGRY | US$3.50B | US$6.21B | n/a | 1.9× | 11.5× | 2.1× | −2.6% | 1.8× | 0.94 |
| Hims & Hers Health, Inc. · NYSE:HIMS | US$3.30B | US$4.15B | n/a | 1.4× | n/a | 9.3× | −6.7% | 4.4× | 2.64 |
| Acadia Healthcare Company, Inc. · NASDAQ:ACHC | US$3.22B | US$5.41B | n/a | 1.6× | 10.1× | 1.6× | −33.1% | 1.2× | 0.82 |
| Privia Health Group, Inc. · NASDAQ:PRVA | US$3.20B | US$2.76B | 92.1× | 1.1× | 43.3× | 3.9× | 1.4% | 0.0× | 0.23 |
| National HealthCare Corporation · AMEX:NHC | US$2.99B | US$3.27B | 26.1× | 2.1× | 16.0× | 2.7× | 7.2% | 0.5× | 0.37 |
| Guardian Pharmacy Services, Inc. · NYSE:GRDN | US$2.97B | US$2.86B | 39.8× | 2.0× | 24.3× | 10.6× | 5.1% | 0.0× | 0.70 |
| Sinopharm Group Co., Ltd. Class H · HKEX:1099 | US$2.88B | US$8.80B | 2.7× | 0.1× | 2.9× | 0.2× | 1.2% | 0.9× | n/a |
| KPJ Healthcare Bhd. · MYX:KPJ | US$2.85B | US$3.53B | 29.3× | 3.2× | 14.2× | 3.9× | 8.9% | 1.3× | n/a |
| Progyny, Inc. · NASDAQ:PGNY | US$2.74B | US$2.57B | 30.1× | 1.9× | 19.2× | 6.6× | 6.8% | 0.1× | -0.09 |
| Pediatrix Medical Group, Inc. · NYSE:MD | US$2.46B | US$2.21B | 16.4× | 1.1× | 9.3× | 2.9× | 7.7% | 0.2× | 0.34 |
| Median of the others | US$2.98B | US$3.40B | 29.3× | 1.7× | 14.2× | 3.4× | 3.3% | 0.7× | 0.53 |
Forecasts
Analysts' consensus from EODHD, read Nov 9, 2026. Not 6ix's view and not investment advice.
- Price target
- 1996.67 INR · Analysts' mean
- EPS, year to Mar 2027
- 53.81 · 7 analysts
- Revenue, year to Mar 2027
- 59.18B · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Chris Fowler | CEO, TruBridge and Group Chief Strategy Officer |
| Sachin K. Gupta | Founder and Global CEO |
| Nithya Balasubramanian | Whole-time Director and CFO |
| Peter Limeri | Group Chief Operating Officer |
| Christi Braun | Group Chief Legal and Compliance Officer |
| Sameer Chavan | Company Secretary & Compliance Officer |
| Sameer Arora | SVP, Investor Relations & Communications |
| Ajay Madatiparambil | EVP, Strategic Partnerships |
| Amit Pande | SVP, Audit, Risk and Compliance |
| David Wang | EVP and GM, Value Based Care Business Unit |
| Deval Majmudar | EVP and Co-GM, Hospitals and Health Systems Business Unit |
| Gaurav Jain | EVP and Co-GM, Ambulatory Care and Medical Groups Business Unit |
| Jamie Gier | SVP and CMO, Hospitals and Health Systems Business Unit |
| Jason Kolinoski | EVP and GM, Clinical Documentation Business Unit |
| Kareen Ribeiro Majmudar | SVP, Performance, Rewards and Talent COE |
| Mangesh Bhide | SVP, India Human Resources Head |
| Mayank Pant | EVP and Co-GM, Ambulatory Care and Medical Groups Business Unit |
| Mike Paoletti | SVP, US Human Resources Head |
| Roland Haas | SVP, AI Foundation |
| Sarah Bennight | SVP and CMO, Ambulatory Care and Medical Groups Business Unit |
| Sarah Caldwell | VP, Human Resources |
| Saransh Mundra | VP, Head Business Finance |
| Siddharth Thakkar | SVP and GM, IKS Platform Business Unit |
| Sri Madabushi | EVP and Co-GM, Hospitals and Health Systems Business Unit |
| Tij Bedi | EVP and GM, Outpatient Rehab Business Unit |
| Venkatkrishnan Ramakrishnan | SVP, Technology GCC |
| Ajai Sehgal | Group Chief AI Officer |
| Amaris McComas | Group Chief Human Resources Officer |
| Grace Terrell | Chief Medical Officer |
| Joe Benardello | Co-founder and Group Chief Growth Officer |
| Kalaiselvan Durairaj | Chief Information Officer |
| Kathryn Weismantel | Group Chief Marketing Officer |
| Kevin Conroy | Group Chief Alliances Officer |
| Mary E. Klotman | Dean, Vice Chancellor and Chief Academic Officer, Duke University School of Medicine |
| Taylor Curtis | Chief Corporate Development Officer |
Board
| Director | Role |
|---|---|
| Clarence Carleton King | Non-Executive Chairman and Independent Director |
| Garheng Kong | Independent Director |
| Keith A. Jones | Director |
| Sachin K. Gupta | Founder and Global CEO |
| Theresa Stone | Independent Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Inventurus Knowledge Solutions (NSE:IKS) Q2 2026 Earnings Call | Fri, Nov 06, 2026 · 5:30 AM ET | Replay |
| Inventurus Knowledge Solutions (NSE:IKS) Q1 2026 Earnings Call | Thu, Aug 06, 2026 · 5:45 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2026 | Nov 5, 2026 · After close | −5.7% |
| Q1 2027 | Aug 5, 2026 · After close | −6.1% |
| Q4 2026 | May 13, 2026 · Before open | +1.3% |
| Q3 2026 | Feb 4, 2026 · Before open | −1.8% |
| Q2 2026 | Oct 30, 2025 · After close | +5.0% |
| Q1 2026 | Jul 31, 2025 · After close | +0.9% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 FY27 Earnings Presentation | Earnings | 19 slides | Nov 5, 2026 |
| Q2 FY27 Earnings Presentation | Earnings | 18 slides | November 2026 |
| Q1 FY27 Earnings Presentation | Earnings | 18 slides | Aug 5, 2026 |
| Q4 FY26 Earnings Presentation | Earnings | 34 slides | May 13, 2026 |
| Merger or Acquisition (April 2026) | Merger or acquisition | 28 slides | Apr 23, 2026 |
| Q3 FY2026 Earnings Presentation | Earnings | 16 slides | Feb 4, 2026 |
| IKS Health — Q4 FY26 Earnings Presentation | Earnings | 33 slides | 2026 |
| Q3 FY26 Earnings Presentation | Earnings | 15 slides | 2026 |
| IKS Health — Q1 FY27 Earnings Presentation | Earnings | 17 slides | 2026 |
| Q2 FY26 Earnings Presentation | Earnings | 23 slides | Oct 30, 2025 |
All 19 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 FY26 Earnings Presentation | Earnings | 22 slides | Oct 30, 2025 |
| Q1 FY26 Earnings Presentation | Earnings | 18 slides | Jul 31, 2025 |
| Merger or Acquisition (July 2025) | Merger or acquisition | 20 slides | Jul 3, 2025 |
| Q4 FY25 Earnings Presentation | Earnings | 19 slides | May 15, 2025 |
| Q3 FY25 Earnings Presentation | Earnings | 16 slides | Feb 5, 2025 |
| IKS Health — Q3 FY25 Earnings Presentation | Earnings | 15 slides | 2025 |
| Q4 FY25 Earnings Presentation | Earnings | 18 slides | 2025 |
| Q1 FY26 Earnings Presentation | Earnings | 17 slides | 2025 |
| Conference Presentation | Conference | 19 slides |
Financials
Annual, in INR
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 31.9B | 26.6B | 18.2B | 10.3B | 7.64B | 5.53B |
| Cost of revenue | 17.5B | 7.47M | 7.14M | 5.26B | 3.82B | 3.06B |
| Gross profit | 14.4B | 26.6B | 18.2B | 5.05B | 3.82B | 2.47B |
| Selling, general and administrative | 1.61B | 19.2M | 1.19B | 354.6M | 280.8M | 1.56M |
| Operating income | 10.3B | 6.57B | 4.66B | 3.74B | 2.79B | 2.45B |
| Depreciation and amortization | 1.24B | 1.13B | 585.5M | 245.5M | 233.1M | 233.1M |
| EBITDA | 11.5B | 7.70B | 5.25B | 3.98B | 3.02B | 2.69B |
| Interest expense | 702.5M | 897.6M | 610.8M | 60.5M | 71.5M | 71.5M |
| Income before tax | 9.05B | 6.06B | 4.42B | 3.59B | 2.69B | 1.83B |
| Income tax | 1.83B | 1.20B | 711.8M | 541.1M | 355.5M | 172.8M |
| Net income | 7.22B | 4.86B | 3.70B | 3.05B | 2.33B | 1.65B |
| Earnings per share, basic | 42.26 | 28.62 | 21.59 | 17.79 | 13.58 | 9.99 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 3.89B | 1.80B | 1.44B | 1.24B | 1.46B | 533.8M |
| Short-term investments | 2.20B | 118.8M | 3.40B | 3.99B | 2.01B | 1.71B |
| Receivables | 5.66B | 5.32B | 3.62B | 1.61B | 959.2M | 756.3M |
| Inventory | 580.0K | 0 | 7.47M | 0 | 0 | |
| Current assets | 13.1B | 7.84B | 8.98B | 6.98B | 4.61B | 3.45B |
| Goodwill | 13.3B | 12.0B | 11.7B | 0 | 0 | |
| Total assets | 42.7B | 30.5B | 30.3B | 9.88B | 7.88B | 5.86B |
| Accounts payable | 1.49B | 759.6M | 677.4M | 216.9M | 96.5M | 69.4M |
| Current liabilities | 9.70B | 5.21B | 7.90B | 1.15B | 828.2M | 588.3M |
| Long-term debt | 2.75B | 5.09B | 8.12B | 0 | 0 | |
| Total debt | 7.53B | 8.56B | 13.1B | 523.5M | 651.9M | 760.3M |
| Total liabilities | 14.7B | 12.6B | 18.7B | 1.60B | 1.40B | 1.29B |
| Shareholders' equity | 28.0B | 17.9B | 11.6B | 8.29B | 6.47B | 4.57B |
| Shares outstanding | 170.7M | 169.8M | 171.6M | 171.6M | 171.6M | 165.6M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Cash from operations | 6.32B | 3.18B | 2.10B | 2.88B | 2.33B | 1.75B |
| Capital spending | -315.2M | -246.9M | -327.1M | -85.5M | -109.0M | -70.3M |
| Free cash flow | 6.00B | 2.93B | 1.77B | 2.79B | 2.22B | 1.68B |
| Cash from investing | -2.15B | 2.44B | -11.4B | -1.56B | -824.5M | -1.66B |
| Cash from financing | -3.65B | -3.89B | 7.80B | -1.52B | -585.1M | -365.7M |
| Dividends paid | -1.65B | -442.6M | -193.3M | |||
| Share buybacks | 0 | -229.6M | -1.45M | -1.14B | -1.34M | -11.2M |
| Change in cash | 2.08B | 1.70B | -1.47B | -220.6M | 923.0M | 533.8M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Inventurus Knowledge Solutions Limited has informed the Exchange regarding a press release dated November 05, 2026, titled "IKS Health s Q2 FY27 Earnings Reflect Strong Momentum with 104 % Revenue and 62.5% EBITDA YoY Growth." | Nov 5, 2026 | Other filings | NSE India |
| Inventurus Knowledge Solutions Limited Press Release Aug 05 2026 | Aug 5, 2026 | Results | NSE India |
| Inventurus Knowledge Solutions Limited Press Release Jul 09 2026 | Jul 9, 2026 | Acquisition or disposal | NSE India |
| Inventurus Knowledge Solutions Limited Press Release Jun 30 2026 | Jun 30, 2026 | Operations update | NSE India |
| Press Release May 13 2026 | May 13, 2026 | Other filings | NSE India |
| Press Release May 05 2026 | May 5, 2026 | Other filings | NSE India |
| Press Release Apr 23 2026 | Apr 23, 2026 | Acquisition or disposal | NSE India |
| Press Release Apr 15 2026 | Apr 15, 2026 | Operations update | NSE India |
| Press Release Apr 07 2026 | Apr 7, 2026 | Operations update | NSE India |
| Press Release Mar 31 2026 | Mar 31, 2026 | Acquisition or disposal | NSE India |
All 22 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Press Release Mar 24 2026 | Mar 24, 2026 | Other filings | NSE India |
| Press Release Mar 18 2026 | Mar 18, 2026 | Other filings | NSE India |
| Press Release Feb 04 2026 | Feb 4, 2026 | Results | NSE India |
| Press Release Nov 25 2025 | Nov 25, 2025 | Other filings | NSE India |
| Press Release Oct 30 2025 | Oct 30, 2025 | Results | NSE India |
| Press Release Oct 16 2025 | Oct 16, 2025 | Other filings | NSE India |
| Press Release Sep 22 2025 | Sep 22, 2025 | Other filings | NSE India |
| Press Release Jul 31 2025 | Jul 31, 2025 | Results | NSE India |
| Press Release Jul 01 2025 | Jul 1, 2025 | Other filings | NSE India |
| Press Release May 15 2025 | May 15, 2025 | Other filings | NSE India |
| Press Release May 07 2025 | May 7, 2025 | Other filings | NSE India |
| Press Release Feb 05 2025 | Feb 5, 2025 | Results | NSE India |
Cap table
Built by 6ix from Inventurus Knowledge Solutions Limited’s releases
- Common shares
- 167,757,449
- Fully diluted
- 167,757,449
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 167,757,449 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 167,757,449 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Ajai Sehgal | Group Chief AI Officer · Since at least Sep 2, 2025 |
| Ajay Madatiparambil | EVP, Strategic Partnerships · Since at least Nov 4, 2026 |
| Amaris McComas | Group Chief Human Resources Officer · Since at least Nov 4, 2026 |
| Amit Pande | SVP, Audit, Risk and Compliance · Since at least Nov 4, 2026 |
| Chris Fowler | CEO, TruBridge and Group Chief Strategy Officer · Since at least Apr 23, 2026 |
| Christi Braun | Group Chief Legal and Compliance Officer · Since at least Nov 20, 2025 |
| Christopher J. Sclafani | Since at least Nov 6, 2026 |
| Clarence Carleton King | Non-Executive Chairman and Independent Director · Since at least Nov 6, 2026 |
| David Wang | EVP and GM, Value Based Care Business Unit · Since at least Nov 4, 2026 |
| Deval Majmudar | EVP and Co-GM, Hospitals and Health Systems Business Unit · Since at least Nov 4, 2026 |
All 40 people
| Person | Seat |
|---|---|
| Garheng Kong | Independent Director · Since at least Nov 6, 2026 |
| Gaurav Jain | EVP and Co-GM, Ambulatory Care and Medical Groups Business Unit · Since at least Nov 4, 2026 |
| Grace Terrell | Chief Medical Officer · Since at least Mar 19, 2025 |
| Jamie Gier | SVP and CMO, Hospitals and Health Systems Business Unit · Since at least Apr 23, 2026 |
| Jason Kolinoski | EVP and GM, Clinical Documentation Business Unit · Since at least Feb 4, 2026 |
| Joe Benardello | Co-founder and Group Chief Growth Officer · Since at least Jul 1, 2025 |
| Kalaiselvan Durairaj | Chief Information Officer · Since at least Nov 4, 2026 |
| Kareen Ribeiro Majmudar | SVP, Performance, Rewards and Talent COE · Since at least Nov 4, 2026 |
| Kathryn Weismantel | Group Chief Marketing Officer · Since at least Nov 20, 2025 |
| Keith Jones | Director · Since at least Nov 6, 2026 |
| Kevin Conroy | Group Chief Alliances Officer · Since at least Nov 4, 2026 |
| Mangesh Bhide | SVP, India Human Resources Head · Since at least Nov 4, 2026 |
| Mary Klotman | Dean, Vice Chancellor and Chief Academic Officer, Duke University School of Medicine · Since at least Nov 6, 2026 |
| Mayank Pant | EVP and Co-GM, Ambulatory Care and Medical Groups Business Unit · Since at least Nov 4, 2026 |
| Mike Paoletti | SVP, US Human Resources Head · Since at least Nov 4, 2026 |
| Nithya Balasubramanian | Whole-time Director and CFO · Since at least Nov 20, 2025 |
| Peter Limeri | Group Chief Operating Officer · Since at least Nov 4, 2026 |
| Roland Haas | SVP, AI Foundation · Since at least Nov 4, 2026 |
| Sachin K. Gupta | Founder and Global CEO · Since at least Apr 23, 2026 |
| Sameer Arora | SVP, Investor Relations & Communications · Since at least Apr 23, 2026 |
| Sameer Chavan | Company Secretary & Compliance Officer · Since at least Nov 4, 2026 |
| Sarah Bennight | SVP and CMO, Ambulatory Care and Medical Groups Business Unit · Since at least Nov 4, 2026 |
| Sarah Caldwell | VP, Human Resources · Since at least Nov 4, 2026 |
| Saransh Mundra | VP, Head Business Finance · Since at least Apr 23, 2026 |
| Siddharth Thakkar | SVP and GM, IKS Platform Business Unit · Since at least Nov 4, 2026 |
| Sri Madabushi | EVP and Co-GM, Hospitals and Health Systems Business Unit · Since at least Feb 13, 2025 |
| Taylor Curtis | Chief Corporate Development Officer · Since at least Nov 4, 2026 |
| Theresa Stone | Independent Director · Since at least Nov 6, 2026 |
| Tij Bedi | EVP and GM, Outpatient Rehab Business Unit · Since at least Nov 4, 2026 |
| Venkatkrishnan Ramakrishnan | SVP, Technology GCC · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about Inventurus Knowledge Solutions Limited.